Literature DB >> 35377171

Draft Genome Sequences of Two Acinetobacter soli Clinical Isolates from a Tertiary Hospital in Terengganu, Malaysia.

Farahiyah Mohd Rani1, Nor Iza A Rahman1, Salwani Ismail1, David W Cleary2,3, Stuart C Clarke2,3,4,5, Chew Chieng Yeo1.   

Abstract

We report the draft genome sequences of Acinetobacter soli AC1511 and AC15148, which were isolated from a tertiary hospital in Terengganu, Malaysia, in 2015. AC1511 was assembled into 43 contigs with a total genome size of 3,320,693 bp, whereas AC15148 was 3,260,687 bp over 47 contigs.

Entities:  

Year:  2022        PMID: 35377171      PMCID: PMC9022556          DOI: 10.1128/mra.00082-22

Source DB:  PubMed          Journal:  Microbiol Resour Announc        ISSN: 2576-098X


ANNOUNCEMENT

Bacteria of the genus Acinetobacter are opportunistic pathogens, and although A. baumannii is the most clinically important species due to its multidrug-resistant characteristics, other non-baumannii species, such as A. nosocomialis, A. pittii, and A. soli, are known etiologic agents of nosocomial infections (1). Here, we report the draft genome sequences of two A. soli isolates, AC1511 and AC15148, from Hospital Sultanah Nur Zahirah (Terengganu, Malaysia). Ethical approval for the collection of isolates was obtained from the Medical Research and Ethics Committee review board of the Malaysian Ministry of Health (protocol number NMRR-14-1650-23625 [IIR]). AC1511 was isolated from the sputum of a 59-year-old female patient with community-acquired pneumonia in 2015, whereas AC15148 was isolated from the blood of a 3-year-old boy with acute tonsillopharyngitis in 2018. AC1511 and AC15148 were identified as A. soli by PCR-amplification and sequencing of the rpoB gene (2, 3). Antimicrobial susceptibility was determined using CLSI breakpoints (4) by obtaining the MIC values using Etest strips for carbapenems and cephalosporins and broth microdilution for polymyxins, whereas disc diffusion was used for other antimicrobials. Both A. soli AC1511 and A. soli AC15148 were susceptible to all antibiotics tested—the carbapenem class (i.e., imipenem, meropenem, and doripenem), cephalosporins (cefotaxime, ceftriaxone, ceftazidime, and cefepime), β-lactam/β-lactamase inhibitor combinations (piperacillin/tazobactam and ampicillin/sulbactam), aminoglycosides (amikacin, gentamicin, and tobramycin), trimethoprim/sulfamethoxazole, fluoroquinolones (ciprofloxacin and levofloxacin), tetracyclines (tetracycline, doxycycline, and minocycline), and polymyxins (polymyxin B and colistin). Genomic DNA was isolated using the Geneaid Presto mini-genomic DNA (gDNA) bacterial kit from a 5-mL overnight culture grown at 37°C in Luria broth. The Nextera XT DNA library preparation kit (Illumina) was used to prepare genomic DNA libraries, which were sequenced on the Illumina HiSeq platform (2 × 150-bp paired-end reads) by a commercial sequencing provider (Novogene) with quality inspection carried out using FastQC v0.11.8 and MultiQC v1.7 (5). The draft genome sequences were assembled using SPAdes v3.11.1 (6). For all software, default parameters were used except where otherwise noted. The genome of A. soli AC1511 was assembled into 43 contigs (N50 value of 246,341 bp, GC content of 43.1%, genome coverage of 150×) with a total genome size of 3,320,693 bp. The A. soli AC15148 genome size was 3,260,687 bp and was assembled into 47 contigs with an N50 value of 173,816 bp, GC content of 42.7%, and genome coverage of 150×. In comparison with the reference A. soli strain, GFJ2 (GenBank version number GCF_001953195.1), the genome of AC1511 showed an average nucleotide identity (ANI) of 98.47% using the BLAST algorithm (ANIb) and 98.7% using the MUMmer alignment tool (ANIm) at JSpeciesWS (7). AC15148 gave an ANIb value of 98.43% and an ANIm value of 98.69% compared with A. soli GFJ2, thus validating the identities of AC1511 and AC15148 as A. soli. Genome annotation was performed using the Prokaryotic Genome Annotation Pipeline v5.1 during sequence submission to NCBI (8). No resistance genes were detected from the genomes of AC1511 and AC15148 using ResFinder (9) and the Comprehensive Antimicrobial Resistance Database (CARD) (10), which confirmed their observed susceptible phenotypes.

Data availability.

The raw reads used for the draft genome sequence assemblies were deposited in the Sequence Read Archive under accession numbers SRR18110793 (for Acinetobacter soli AC1511) and SRR18120237 (for A. soli AC15148). The draft genome sequences of the strains obtained in this study were deposited under BioProject number PRJNA576555 with the assembled genomes under the accession numbers JAGFOS000000000 (A. soli AC1511) and JAGFOR000000000 (A. soli AC15148).
  9 in total

1.  SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing.

Authors:  Anton Bankevich; Sergey Nurk; Dmitry Antipov; Alexey A Gurevich; Mikhail Dvorkin; Alexander S Kulikov; Valery M Lesin; Sergey I Nikolenko; Son Pham; Andrey D Prjibelski; Alexey V Pyshkin; Alexander V Sirotkin; Nikolay Vyahhi; Glenn Tesler; Max A Alekseyev; Pavel A Pevzner
Journal:  J Comput Biol       Date:  2012-04-16       Impact factor: 1.479

2.  Validation of partial rpoB gene sequence analysis for the identification of clinically important and emerging Acinetobacter species.

Authors:  Vijay A K B Gundi; Lenie Dijkshoorn; Sophie Burignat; Didier Raoult; Bernard La Scola
Journal:  Microbiology       Date:  2009-04-23       Impact factor: 2.777

3.  Sequencing of the rpoB gene and flanking spacers for molecular identification of Acinetobacter species.

Authors:  Bernard La Scola; Vijay A K B Gundi; Atieh Khamis; Didier Raoult
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

4.  MultiQC: summarize analysis results for multiple tools and samples in a single report.

Authors:  Philip Ewels; Måns Magnusson; Sverker Lundin; Max Käller
Journal:  Bioinformatics       Date:  2016-06-16       Impact factor: 6.937

5.  An Acinetobacter non-baumannii Population Study: Antimicrobial Resistance Genes (ARGs).

Authors:  Adam Baraka; German M Traglia; Sabrina Montaña; Marcelo E Tolmasky; Maria Soledad Ramirez
Journal:  Antibiotics (Basel)       Date:  2020-12-26

6.  NCBI prokaryotic genome annotation pipeline.

Authors:  Tatiana Tatusova; Michael DiCuccio; Azat Badretdin; Vyacheslav Chetvernin; Eric P Nawrocki; Leonid Zaslavsky; Alexandre Lomsadze; Kim D Pruitt; Mark Borodovsky; James Ostell
Journal:  Nucleic Acids Res       Date:  2016-06-24       Impact factor: 16.971

7.  JSpeciesWS: a web server for prokaryotic species circumscription based on pairwise genome comparison.

Authors:  Michael Richter; Ramon Rosselló-Móra; Frank Oliver Glöckner; Jörg Peplies
Journal:  Bioinformatics       Date:  2015-11-16       Impact factor: 6.937

8.  CARD 2020: antibiotic resistome surveillance with the comprehensive antibiotic resistance database.

Authors:  Brian P Alcock; Amogelang R Raphenya; Tammy T Y Lau; Kara K Tsang; Mégane Bouchard; Arman Edalatmand; William Huynh; Anna-Lisa V Nguyen; Annie A Cheng; Sihan Liu; Sally Y Min; Anatoly Miroshnichenko; Hiu-Ki Tran; Rafik E Werfalli; Jalees A Nasir; Martins Oloni; David J Speicher; Alexandra Florescu; Bhavya Singh; Mateusz Faltyn; Anastasia Hernandez-Koutoucheva; Arjun N Sharma; Emily Bordeleau; Andrew C Pawlowski; Haley L Zubyk; Damion Dooley; Emma Griffiths; Finlay Maguire; Geoff L Winsor; Robert G Beiko; Fiona S L Brinkman; William W L Hsiao; Gary V Domselaar; Andrew G McArthur
Journal:  Nucleic Acids Res       Date:  2020-01-08       Impact factor: 16.971

9.  ResFinder 4.0 for predictions of phenotypes from genotypes.

Authors:  Valeria Bortolaia; Rolf S Kaas; Etienne Ruppe; Marilyn C Roberts; Stefan Schwarz; Vincent Cattoir; Alain Philippon; Rosa L Allesoe; Ana Rita Rebelo; Alfred Ferrer Florensa; Linda Fagelhauer; Trinad Chakraborty; Bernd Neumann; Guido Werner; Jennifer K Bender; Kerstin Stingl; Minh Nguyen; Jasmine Coppens; Basil Britto Xavier; Surbhi Malhotra-Kumar; Henrik Westh; Mette Pinholt; Muna F Anjum; Nicholas A Duggett; Isabelle Kempf; Suvi Nykäsenoja; Satu Olkkola; Kinga Wieczorek; Ana Amaro; Lurdes Clemente; Joël Mossong; Serge Losch; Catherine Ragimbeau; Ole Lund; Frank M Aarestrup
Journal:  J Antimicrob Chemother       Date:  2020-12-01       Impact factor: 5.790

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.